Correlation Between Innerscope Advertising and BioLife Sciences
Can any of the company-specific risk be diversified away by investing in both Innerscope Advertising and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innerscope Advertising and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innerscope Advertising Agency and BioLife Sciences, you can compare the effects of market volatilities on Innerscope Advertising and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innerscope Advertising with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innerscope Advertising and BioLife Sciences.
Diversification Opportunities for Innerscope Advertising and BioLife Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Innerscope and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Innerscope Advertising Agency and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and Innerscope Advertising is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innerscope Advertising Agency are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of Innerscope Advertising i.e., Innerscope Advertising and BioLife Sciences go up and down completely randomly.
Pair Corralation between Innerscope Advertising and BioLife Sciences
Given the investment horizon of 90 days Innerscope Advertising is expected to generate 3.53 times less return on investment than BioLife Sciences. But when comparing it to its historical volatility, Innerscope Advertising Agency is 1.88 times less risky than BioLife Sciences. It trades about 0.06 of its potential returns per unit of risk. BioLife Sciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 0.20 in BioLife Sciences on November 2, 2024 and sell it today you would lose (0.19) from holding BioLife Sciences or give up 95.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.0% |
| Values | Daily Returns |
Innerscope Advertising Agency vs. BioLife Sciences
Performance |
| Timeline |
| Innerscope Advertising |
| BioLife Sciences |
Innerscope Advertising and BioLife Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innerscope Advertising and BioLife Sciences
The main advantage of trading using opposite Innerscope Advertising and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innerscope Advertising position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.| Innerscope Advertising vs. BioLife Sciences | Innerscope Advertising vs. CeCors Inc | Innerscope Advertising vs. GlucoTrack | Innerscope Advertising vs. Sharps Technology |
| BioLife Sciences vs. Innerscope Advertising Agency | BioLife Sciences vs. CeCors Inc | BioLife Sciences vs. GlucoTrack | BioLife Sciences vs. Sharps Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |